November 4, 2024

The liver cancer screening market has become crucial as healthcare systems prioritize early diagnosis and preventive measures. With a valuation of USD 11.99 billion in 2023 and an anticipated growth rate of 7.20% CAGR through 2032, this market is expected to hit USD 22.41 billion. Increasing liver cancer rates, new technologies, and broader access to […]

Read More